BOA Biomedical seeks to address antibiotic resistance and sepsis Leave a Comment / Uncategorized / By curtschulz Harvard’s Wyss Institute and VC firm Miraki Innovation have created a joint venture BOA Biomedical, which is developing a device that could diagnose and treat infectious diseases.